| Date | Title | Description |
| 25.06.2024 | Insider Information: Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000 | Company Announcement, Helsinki, 25 June 2024 at 9 AM (EEST)
Insider Information: Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR IN... |
| 07.03.2024 | Nexstim Plc: Invitation to the Annual General Meeting | - |
| 06.03.2024 | Nexstim Plc Publishes 2023 Annual Report | - |
| 25.05.2021 | Nexstim extends agreement with Canadian distributor and receives order for three NBT® systems | Helsinki, Finland: 25 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has extended its agreement with Canadian Health Solutions group, the Company’s distributor in Canada, for an additional five years. |
| 18.05.2021 | Nexstim granted authorization for commercial distribution of NBS system in Australia | Helsinki, Finland: 18 May 2021- Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces having received authorization for distribution of its NBS system by the Australian Therapeutic Goods Administration (TGA). |
| 17.05.2021 | Impressive new study results suggest potential new therapeutic use for Nexstim SmartFocus® nTMS in postsurgical rehabilitation of Paresis | Helsinki, Finland: 17 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Brain Stimulation in May reports that the therapeutic use of Nexstim navigated repetitive transcranial magnetic stimulation (nrTMS) ... |
| 07.05.2021 | Nexstim receives a new NBS system order from a leading California based academic hospital | Helsinki, Finland : 7 May 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received an NBS system order from a distinguished academic hospital based in Northern California, US. |
| 16.04.2021 | Nexstim receives positive feedback from Mind Matters Psychiatry MD on use of their two NBT® systems to treat MDD | Helsinki, Finland: 16 april 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with dep... |
| 12.03.2021 | Nexstim gives an update on its promising treatment results of Major Depressive Disorder | Helsinki, Finland: 12 March 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports very promising clinical outcomes of the 159 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder ... |
| 28.01.2021 | German University Hospital orders Nexstim NBS system with NexSpeech | Helsinki, Finland: 28 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a University Hospital in Germany has ordered a Nexstim NBS System with NexSpeech. |
| 13.01.2021 | New study presents impressive results of Nexstim SmartFocus® nTMS Language Mapping | Helsinki, Finland: 13 January 2021 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the robustness of N... |
| 22.12.2020 | Nexstim has received three new NBS System orders | Helsinki, Finland: 22 December 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that it has received three new NBS system orders in December. |
| 05.10.2020 | Nexstim continues to report promising results in quickly growing number of patients completing SmartFocus® rTMS treatment of Major Depressive Disorder | Helsinki, Finland: 5 October 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports very promising clinical outcomes of the 108 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder... |
| 04.09.2020 | BrainStim Centers orders a second Nexstim NBT® System with SmartFocus® TMS | Helsinki, Finland: 4 September 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that BrainStim Centers, US has ordered a second Nexstim NBT® System with SmartFocus® TMS technology. |
| 17.04.2020 | Nexstim reports promising clinical outcomes of first 55 patients completing SmartFocus® rTMS treatment of Major Depressive Disorder | Helsinki, Finland: 17 April 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) reports the clinical outcomes of the first 55 patients who have completed SmartFocus® rTMS therapy for treatment of major depressive disorder (MDD) at clinical sites in t... |
| 28.02.2020 | Nexstim Plc financial statements release 2019 | Helsinki, Finland: 28 February 2020 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), today provides its financial statements for the full year 2019 (1 January–31 December 2019) and H2 2019 (1 July-31 December 2019). |
| 05.12.2019 | Nexstim Plc: Health Canada grants Nexstim NBT® Medical Device License for Canada | Helsinki, Finland: 5 December 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada. |
| 18.11.2019 | Nexstim Plc: Shares subscribed for in the directed share issue have been registered | Helsinki, Finland: 18 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announced on 15 November 2019 that an aggregate of 15,687,350 new shares of Nexstim were subscribed for in the directed share issue. Such new shares have today been re... |
| 11.11.2019 | Dr Leena Niemistö starts as new Chair of the Board of Nexstim Plc | Helsinki, Finland: 11 November 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that the Extraordinary General Meeting of Shareholders has elected Leena Niemistö as the new Chair of the Board of Directors. |
| 14.10.2019 | Nexstim has placed an NBT® System with SmartFocus® technology to Stanford University Medical Center | Helsinki, Finland: 14 October 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD) – announces that it has place... |
| 27.09.2019 | Nexstim New System Sales Update | Helsinki, Finland: 27 September 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”)—the company developing and marketing a unique brain stimulation technology for diagnostics and therapy—announces it has sold one NBS System a... |
| 05.08.2019 | Nexstim NBT® system authorized for commercial distribution in Australia | Helsinki, Finland: 5 August 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of major depre... |
| 03.07.2019 | Second Nexstim NBT® system ordered by Island Psychiatry PC, US | Helsinki, Finland: 3 July 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the targeted neuromodulation company developing and marketing pioneering navigated personalized, non-invasive brain stimulation systems for the treatment of Major Depress... |
| 26.06.2019 | Finnish spinal cord injury rehabilitation research using Nexstim SmartFocus™ technology receives significant funding from Wings for Life Foundation | Helsinki, Finland: 26 June 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated, personalised and non-invasive brain stimulation systems for diagnostics and therapy – today annou... |
| 18.06.2019 | Leading Austrian Clinic, Klinik Pirawarth, Provides Positive Feedback on its First Nexstim NBT® System for Treatment of Depression and Pain | Helsinki, Finland: 18 June 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depress... |
| 28.05.2019 | Nexstim NBS system sold to the Jewish General Hospital in Canada | Helsinki, Finland: 28 May 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) – the targeted neuromodulation company developing and marketing pioneering, navigated, personalised, non-invasive brain stimulation systems for diagnostics and therapy – to... |
| 22.05.2019 | Nexstim sells first NBT® system in Germany for depression therapy and research | Helsinki, Finland: 22 May 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressi... |
| 10.05.2019 | Nexstim enters depression therapy market in Sweden | Helsinki, Finland: 10 May 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressi... |
| 24.04.2019 | Professor Paul Fitzgerald joins Nexstim’s Scientific Advisory Board | Helsinki, Finland: 24 April 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalized, non-invasive brain stimulation systems for the treatment of Major Depres... |
| 14.01.2019 | Nexstim Plc Depression Therapy Business Update | Helsinki, Finland: 14 January 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depr... |
| 07.01.2019 | Nexstim Plc signs Canadian distribution agreement for its SmartFocus™ TMS systems with Canadian Health Solutions CHS | Helsinki, Finland: 7 January 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depre... |
| 25.10.2018 | Nexstim secures Business Finland funding for the development of wireless EMG devices | Helsinki, Finland: 25 October 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing, and marketing pioneering navigated personalised, non-invasive brain stimulation systems for the treatment of Major Dep... |
| 28.09.2018 | Nexstim Plc supports 10th International Symposium on Navigated Brain Stimulation in Neurosurgery and Neuromodulation | Helsinki, Finland: 28 September 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applica... |
| 19.09.2018 | Nexstim Plc to present depression led strategy at Investor Conference Sijoittaja 2018 in Helsinki | Helsinki, Finland: 19 September 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing navigated personalised, non-invasive brain stimulation systems for the treatment of Major Depressive Di... |
| 16.08.2018 | Nexstim Plc half-yearly report 1 January – 30 June 2018 (Unaudited) | Helsinki, Finland: 16 August 2018 – Highlights, January-June 2018 |
| 22.05.2018 | Nexstim Plc – first NBT® system for depression ordered in the US | Helsinki, Finland: 22 May 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and commercializing its world-leading navigated non-invasive brain stimulation technology for therapeutic and diagnostic ap... |
| 09.05.2018 | Nexstim Plc launches NBT® system for depression at the US Clinical TMS Society Annual Meeting in New York | Helsinki, Finland: 9 May 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application, an... |
| 23.01.2018 | Nexstim Plc receives R&D loan from Business Finland | Helsinki, Finland: 23 January 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, ann... |
| 06.01.2018 | Nexstim enrols last patient in supplementary Phase III E-FIT trial | Helsinki, Finland: 6 January 2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, anno... |
| 11.12.2017 | Nexstim Plc has entered into an agreement on a financing arrangement that is conditional on the approval of the AGM | Helsinki, Finland: 11 December 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, an... |
| 01.12.2017 | Nexstim Plc appoints Steve Beller as Vice President and General Manager | Helsinki, Finland: 1 December 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, ann... |
| 25.10.2017 | Nexstim raises € 1.75 million via a directed issue of new shares to London-based investor City Financial – Funds to be used to support beginning the commercialisation of its NBT® system | Helsinki, Finland: 25 October 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, ann... |
| 16.10.2017 | Nexstim Plc is negotiating an assembly and distribution arrangement in China and a financing arrangement for the financing of its bring-to-market strategy in Europe and the US | Helsinki, Finland: 16 October 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, is ... |
| 03.08.2017 | Changes in Nexstim Plc’s Management Team | Helsinki, Finland: 3 August 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, annou... |
| 27.06.2017 | Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA | Helsinki, Finland: 27 June 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, is ple... |
| 17.05.2017 | Nexstim Plc updates the timeline for its supplementary E-FIT Phase III Trial in Stroke Rehabilitation | Helsinki, Finland: 19 May 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, today p... |
| 25.04.2017 | Aarhus University Hospital in Denmark purchases NBS System from Nexstim Plc | Helsinki, Finland: 24 April 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, annou... |
| 24.04.2017 | Nexstim Plc appoints Hanna Kotola as VP of Legal Affairs | Helsinki, Finland: 24 April 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic (NBT® system) and diagnostic (NBS ... |
| 22.03.2017 | Nexstim Plc signs an Independent Selling Representative Agreement in the US with JTec Surgical | Helsinki, Finland: 22 March 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new ... |
| 08.03.2017 | Nexstim Plc announces signing of an Independent Selling Representative Agreement in the US with Surgical Solutions, Inc | Helsinki, Finland: 8 March 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new I... |
| 07.03.2017 | Nexstim Plc announces the start of patient enrolment in the supplementary Phase III Trial in Stroke Rehabilitation with its NBT system | Helsinki, Finland: 7 March 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system (NBT® system), announces that it has enrolled the first patients in its sup... |
| 31.01.2017 | Neurosurgeons from Germany and USA report on their clinical experience of using Nexstim NBS system | Helsinki, Finland: 31 January 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that, in a recently published clinical article, neurosurgeons... |
| 05.01.2017 | Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco | Helsinki, Finland: 5 January 2017 – Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today announces that Chairman of the Board and Chief Executive Officer, ... |
| 11.05.2011 | Nexstim Oy Receives €2M Equity Financing | Nexstim Oy, a Helsinki, Finland-based medical device company commercializing non-invasive brain diagnostic and therapy technologies, has received a €2m equity financing.
The investment was made by new investor Capricorn Health-tech Fund NV,... |
| 28.01.2011 | Nexstim Raises over €11M in Equity Financing | Nexstim Oy, an Helsinki, Finland-based medical device company commercializing noninvasive brain diagnostic and therapy technologies, has raised over €11m in equity financing.
The round was led by new investor Lundbeckfond Ventures, with par... |
| 05.09.2007 | Life sciences briefing: Thursday, Sept. 6, 2007 | Featured companies: Cyntellect, Lectus Therapeutics, NeoMatrix, Nexstim, Pearl Therapeutics, Proteon Therapeutics, SupplyScape
(UPDATED at 10am PT: See below.)
Airway-disease specialist Pearl Therapeutics raises $15.5M — Redwood City, Calif... |
| - | Nexstim Plc agrees the next steps of the NBT stroke de novo submission with the FDA | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that Nexstim has, on September 14, 2016, discussed the pivotal stroke multicenter trial (NICHE, Na... |
| - | Nexstim Launches Next Generation NBS 5 System | Helsinki, 18 September 2014
New device to be showcased at two international congresses
Nexstim (the “Company”), a medical technology company focused on Navigated Brain Stimulation (NBS), announces the launch of a new NBS system, NBS 5,for... |
| - | Notice of Nexstim Plc’s Half-Yearly Report H1 2018 | Company announcement, Helsinki, 9 August 2018 at 9:00 AM
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or the “Company”), the targeted neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation sys... |
| - | Nexstim Plc Terminates Market Making Agreement with Pareto Securities AB in Nasdaq First North Sweden | Company announcement, Helsinki, 8 May 2017 at 9:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both... |
| - | Nexstim Plc Announces Changes to its Board of Directors | Helsinki, 25th March 2015 at 8:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces that Tim Irish has been... |
| - | NEXSTIM PLC FINANCIAL STATEMENT RELEASE 2014 | Helsinki, 26 February 2015 at 8:00 am
Nexstim listed to Nasdaq First North Helsinki & Stockholm and continued Phase III multi-centre trial in the US
Company Highlights, July – December 2014
Status of clinical development
Nexstim’s N... |
| - | Nexstim Plc announces long-term financing arrangements in the form of a joint deal with Bracknor and Sitra | Company announcement, Helsinki, 21 July 2016, at 9:00 am
Financing arrangements include a convertible bond facility of EUR 5 million, stand-by equity facilities of EUR 5 million and EUR 1.5 million, a directed share issuance of EUR 500,000... |
| - | Key Technology Patent Granted for US | – Strengthened patent estate around Nexstim’s cutting-edge technology
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, ... |
| - | Nexstim Financial Statements Release 2017 | 28 February 2018
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”), a neuromodulation company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, ... |
| - | Nexstim Plc Supports 7th International Symposium on Navigated Brain Stimulation in Neurosurgery | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces its support for the 6th International Symposium on Navigated ... |
| - | Notice of Nexstim Plc’s Half-Yearly Report H1 2017 | 11 August 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications,... |
| - | Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial – Funds to be used to support beginning the commercialisation of its NBT® system | Company announcement, Helsinki, 25 October 2017 at 9:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for b... |
| - | Nexstim announces the result of its private placement | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL.
Further... |
| - | Notice of Nexstim Plc 2017 Full Year Results | 16 February 2018
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application... |
| - | NEXSTIM PLC PUBLISHES 2014 ANNUAL REPORT | Helsinki, 9 March 2015 at 8:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces the publication of its 201... |
| - | Nexstim enrols last patient in supplementary Phase III E-FIT trial | 06 January 2018
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications... |
| - | Nexstim Plc Receives CE Mark Registration for NBT® for Treatment of Chronic Neuropathic Pain | Commercialisation plans commence
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces it has CE marked and released for sales its Navigated Brain Ther... |
| - | Nexstim Plc Announces Completion of Enrolment of Phase III Clinical Trial in Stroke Therapy | Recruitment completed ahead of schedule
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces that it has successf... |
| - | Nexstim Plc Updates the Timeline for its Supplementary E-FIT Phase III Trial in Stroke Rehabilitation | Company announcement, Helsinki, 19 May 2017 at 9:00 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for bot... |
| - | Nexstim Plc announces the change of CEO | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, announces that Janne Huhtala has stepped down as CEO of Nexstim to explore... |
| - | Nexstim Plc Files 510(k) Submission for its NBT® system for the Treatment of Depression with US FDA | 27 June 2017
Company announcement, Helsinki, 27 June 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for b... |
| - | Nexstim Plc Key Technology Patent Granted in US | – Strengthened patent estate around Nexstim’s cutting-edge technology and software
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that the Unite... |
| - | Cook Children’s Hospital in Texas acquires NBS System from Nexstim Plc | Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that Cook Children’s Hospital in Fort Worth, Texas has recently purchased... |
| - | Nexstim Plc announces signing of an Independent Selling Representative Agreements in U.S. | 11 January 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed... |
| - | Nexstim Supports 6th International Symposium on Navigated Brain Stimulation in Neurosurgery | Helsinki, 2 October 2014
Nexstim Oy (“Nexstim” or the “Company”), a medical technology company aiming to improve rehabilitation for stroke patients through the use of noninvasive brain stimulation, announces its support for the 6th Inter... |
| - | Nexstim Plc Receives Interim Analysis Information and Recommendation from DSMB for Phase III Stroke Therapy Trial | Nexstim Plc Receives Interim Analysis Information and Recommendation from DSMB for Phase III Stroke Therapy Trial
Helsinki, 28 February 2016 at 1:00 pm
– Pre-specified stopping criteria for futility have been met and the trial will not me... |
| - | Nexstim Plc Half-Yearly Report 1 January – 30 June 2018 (unaudited) | Company announcement, Helsinki, 16 August 2018 at 9:00 am
Nexstim is a personalised neuromodulation company developing and marketing pioneering precisely navigated non-invasive brain stimulation systems for both therapeutic (NBT® system) a... |
| - | Nexstim Plc SmartFocusTM TMS technology based therapy used across all university hospitals in Finland | Helsinki, 6/18/2018 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”), the targeted neuromodulation company developing and commercializing its world-leading navigated non-invasive brain stimulation technology for therapeutic and... |
| - | Nexstim Plc has entered into an agreement on a financing arrangement that is conditional on the approval of the Annual General Meeting | Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or the “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic applications, announced i... |
| - | Publishing of Nexstim Plc 2016 Full Year Results | 17 February 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, will announce its full year results for the year ended 31 December 2016 in the morning of ... |
| - | NEXSTIM PLC FINANCIAL STATEMENT RELEASE 2016 | 28 February 2017
Company Highlights, July – December 2016
Post period end highlight
Business focus
CEO Martin Jamieson’s review
I am delighted to report the progress that Nexstim has made on multiple fronts during this eventful year in... |
| - | Nexstim gains FDA clearance to commercialise its NBT® system in the US for the treatment of depression | 13 November 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both therapeutic and diagnostic application... |
| - | Nexstim Plc Signs an Independent Selling Representative Agreement in the U.S. with JTec Surgical, Inc. | Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independen... |
| - | Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America | Company announcement, Helsinki, 1 December 2017 at 9 am
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company developing and marketing pioneering navigated non-invasive brain stimulation systems for both... |
| - | NEXSTIM PLC PUBLISHES 2016 ANNUAL REPORT | 06 March 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces the publication of its 2016 Annual Report. These documents are available on the “In... |
| - | Nexstim to present at Biotech Showcase 9th Annual Conference in San Francisco | 05 January 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today announces that Chairman of the Board and Chief Executive Off... |
| - | Nexstim Progresses its Navigated Brain Stimulation Technology in Stroke and Demonstrates Improved Outcomes in Brain Tumor Surgery | Study on track and sites selected and initiated in multicenter clinical trial on the therapeutic effects of NBT® for stroke rehabilitation
Nexstim’s NBS® motor mapping in neurosurgical planning improves outcomes of brain tumor surgery
Hel... |
| - | NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2016 (UNAUDITED) | Company announcement, Helsinki, 17 August 2016 at 9:00 am
Company Highlights, January – June 2016
Post period end highlight
Status of clinical development
The Company has been building clinical evidence by conducting a Phase III multi... |
| - | Data Safety Monitoring Board Recommends Continuation of Nexstim Plc’s Phase III Stroke Therapy Trial | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces today that it has received a recommendation from the Data Saf... |
| - | Nexstim Plc Appoints John Liedtky as VP of Commercialisation, General Manager US and announces the retirement of John Hardin | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients with the use of non-invasive brain stimulation, today announces the appointment of John Liedtky as VP of Commercialization... |
| - | Nexstim Plc submits FDA 510(k) De Novo documentation for NBT® | Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces the submission of FDA 510(k) De Novo documentation for its Navigated Brain Therapy (NBT®) system f... |
| - | Neurosurgeons from Germany and U.S.A. report on their clinical experience of using Nexstim NBS system | Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that, in a recently published clinical article, neurosurgeons report clin... |
| - | Nexstim Plc Announces the Start of Patient Enrolment in the Supplementary Phase III Trial in Stroke Rehabilitation with its NBT system | 07 March 2017
Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company“), a medical technology company with a pioneering navigated non-invasive brain stimulation system (NBT® system), announces that it has enrolled the first patients in i... |
| - | Nexstim launches its Initial Public Offering and will apply for dual listing on Nasdaq First North Finland and Nasdaq First North Sweden | Helsinki,
Following the announcement of its intention to float on 19 September 2014, Nexstim Plc (“Nexstim” or the “Company”) today publishes its prospectus and announces the terms and conditions (including the indicative price range) fo... |
